Radiation
Near Add Your Location
Accepting patients
ACCESS
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide (ACCESS)
- Allogeneic Stem Cell Transplant
- Pre-Transplant
- Phase 2
Accepting patients
Phase I Study of Escalating Doses of 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody Added to the Conditioning Regimen of Fludarabine, Melphalan and Organ Sparing Total Marrow and Lymphoid Irradiation (TMLI) as Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
- Allogeneic Stem Cell Transplant
- Monoclonal Antibody
- CD38
- Phase 1
Accepting patients
UCB Transplant with Myeloablative Prep
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
- Allogeneic Stem Cell Transplant
- Phase 2
Accepting patients
Personalized Natural Killer Cell Therapy
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma
- Natural Killer Cells (Allogeneic)
- Phase 2
Accepting patients
Cytokine-Treated Veto Cells Post-Transplant
Cytokine-Treated Veto Cells in Treating Participants With Hematologic Malignancies Following Stem Cell Transplant
- Allogeneic Stem Cell Transplant
- Phase 1/2
Accepting patients
Myeloablative Allo Stem Cell Transplant
Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematological Disorders
- Allogeneic Stem Cell Transplant
- Phase 2
Showing 1-6 of 6